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rectal cancer, the clinical target volume was delineated and 
for breast cancer, the regional nodal areas (internal 
mammary, level I to IV axillary and Rotter space) were 
contoured. A trained radiation technologist then reviewed all 
cases according to the guidelines and feedback was given 
within 24 hours. Twenty-four departments participated to the 
study and in total more than 2200 contours were reviewed: 
over 1200 rectal cancer patients and over 1000 breast cancer 
patients.Evaluation of the contours showed that 74 % of 
rectal cancer cases were modified. These high numbers 
indicate that the interpretation of guidelines is not always 
straightforward. More important however is the learning 
curve that was achieved. The rectal overlap and volumetric 
parameters significantly increased between the first ten 
patients per center and others. The study of the contouring 
of the locoregional nodal delineation in breast cancer is still 
ongoing and first results will be presented at presented at 
the ESTRO 35. For both breast and rectal cancer, some 
deficiencies in the description of the guidelines were 
demonstrated, making the interpretation ambiguous, and the 
guidelines will be adapted accordingly. Within a national QA 
project, we have shown that clinical audit of target 
delineation improves the quality of the contouring: the inter-
observer variability and the major deviations from the 
guidelines are substantially reduced. Variability in anatomical 
contouring contributes to uncertainty in treatment planning 
and compromises the quality of the treatment plan and 
delivered treatment. The standardization of tumor and target 
volume contouring is therefore highly desirable and can be 
positively influenced by consensus guidelines, education and 
clinical audits. 
 
SP-0292  
Standardisation and treatment planning 
B. Heijmen
1Erasmus MC Cancer Institute, Radiation Oncology, 
Rotterdam, The Netherlands 
1, A. Henry2, S. Breedveld1 
2St James's Institute of Oncology- St James's Hospital, 
Radiation Oncology, Leeds, United Kingdom 
 
Current plan generation is an iterative trial-and-error 
procedure in which the planner tries to steer the treatment 
planning system (TPS) towards an acceptable plan by 
tweaking of parameters, such as beam angles, goal functions 
or weights. A plan is generally considered acceptable if it 
fulfills minimum requirements for tumour and OARs, while 
significant further improvement of the dose distribution is 
considered infeasible (within the allotted time). On top of 
the high workload, the current planning approach leads to 
suboptimal plan quality: the quality is strongly dependent on 
the skills and experience of the planner (operator 
dependence), plan quality is dependent on allotted time, and 
quality is dependent on subjective preferences and priorities 
of the planner and the treating physician. Can this variability 
be reduced? Can treatment planning be standardised? Can we 
guarantee that each patient will be treated with an 
individualised, clinically highly favourable (best) treatment 
plan when generated in an efficient manner? In this 
presentation, data will be provided demonstrating difficulties 
that clinicians encounter in evaluating treatment plans. 
Furthermore, the concept of automated treatment plan 
generation will be discussed as a procedure that may be used 
to standardise treatment planning. Examples of the positive 
impact on plan quality will be presented and consequences 
for involved personnel and plan quality assurance will be 
discussed.  
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Delineation of targets and normal tissues, typically 
performed on CT and/or MR images, is still one of the largest 
sources of variability in radiation therapy treatment plans. In 
fact, despite well-described guidelines for manual 
contouring, substantial intra and inter-observer variations 
exist. Moreover manual contouring is a time consuming 
process that, depending on the number and complexity of 
contours to be delineated, can hinder the implementation of 
adaptive radiotherapy approach. Current perspectives on 
contouring procedure suggest that an automated approach 
could reduce both the contouring time and inter-observer 
variations. Studies evaluating automated contouring in 
multiple disease sites have in fact demonstrated the 
potential to improve efficiency and variability associated 
with manual segmentation. In practice, automated contour 
are carried out using atlas-based, model-based or hybrid 
approaches. In atlas-based segmentation the CT scan of a 
new patient is segmented using segmented scans of one 
(single-patient) or more (multi-patient) previously treated 
patients, called atlases. Methods based on classical 
deformable models use local image features and 
automatically adapts the model shape to fit patient’s organ. 
Various implementations of these two principal methods are 
described in the literature and are available in commercial 
contouring software. Prior their clinical use automated 
contouring methods need an accurate validation. This is a 
challenging task as medical image segmentation lacks a 
known gold standard in its real world application. Phantoms 
as well as synthetic images provide an easily identifiable 
ground truth but are an unrealistic surrogate for patient 
imaging. Moreover, evaluation methods have also lacked 
consensus as to comparison metrics. A number of different 
methods have been utilized for comparing segmentation 
results. The common metrics used fall into one of two 
categories: volume based or distance based. Each of the 
comparison metrics has limitations and thus it is desirable to 
use multiple metrics where possible. This presentation will 
discuss the advantage in standardization deriving from the 
use of automatic contouring and the different approach 
followed in the implementation and validation of automated 
segmentation tools in different anatomical districts.  
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Standardisation of clinical practice is essential for the 
delivery of safe, accurate radiotherapy treatments. 
Implementation of new standards can be at both local and 
national levels and examples of these approaches, from an 
RTT perspective, will be discussed. New standards should be 
developed and implemented within a multi-professional team 
setting. Each profession has a role to play and bring different 
perspectives to the development and implementation 
process. 
Development of training and competency assessments for the 
use of new delivery techniques are an essential aspect of 
implementing any new standards. These assessments can be 
established locally using national guidelines. For example the 
UK National Radiotherapy Implementation Group IGRT 
recommendations1 which was written by a multi-profession 
team to assist centres in utilising IGRT equipment and details 
content for IGRT training and competency assessment 
programmes. This recommendation document has been 
instrumental in the UK with ensure appropriate utilisation of 
IGRT for each anatomical site and ensuring quality IGRT is 
delivered to patients. RTTs are also involved in the 
preparation of national SABR guidelines, as part of the UK 
SABR consortium, particularly focusing on the treatment 
delivery and IGRT sections. 
Clinical trials provide a controlled environment where new 
standards can be developed in a quality assured way. A UK 
prostate radiotherapy clinical trial utilised both IMRT and 
IGRT within the context of a study evaluating a number of 
fractionation schedules. This assisted the centres involved to 
develop IMRT and IGRT standards within their departments 
within a quality assured clinical trial. RTTs were able to use 
IGRT processes clearly defined within the protocol and the 
support of the QA team for the trial were available for advice 
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and support. This same method is currently being adopted in 
the UK for a number of adaptive radiotherapy trials and this 
will assist in establishing new evidence for adaptive 
radiotherapy and the community will be prepared for routine 
implementation if the results favour an adaptive approach. 
It is important to consider the role of QA together with audit 
programmes both during the implementation phase and also 
on a routine basis following the implementation of the new 
evidence based standards. RTTs are a key component of this 
process within the multi-professional team. 
Conclusion  
Utilisation of national recommendations or clinical trial 
processes ensure that new standards are developed and 
implemented safely and accurately. There is sometimes a 
tendency to slowly adopt new technologies and evidenced 
based practice into routine practice but by having national 
protocols, quality assurance and multi-centre clinical trials, 
new standards can be implemented timely, appropriately and 
safely. 
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Purpose or Objective: Very recently, the DAHANCA, EORTC, 
GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG 
consensus guidelines for delineating organs at risk (OARs) in 
the head and neck region have been published (1). The 
purpose of this study was to investigate whether these 
international consensus guidelines improved delineation 
quality among observers. 
 
Material and Methods: Ten radiation oncologists, considered 
experts in the field, were asked to delineate 20 different 
OARs on CT images (2 mm slice thickness) in two delineation 
sessions. The first session was performed in 2013 without the 
use of any predefined guidelines. The second session was 
performed in 2015 just after publication of the consensus 
guidelines. The observer variation was measured in 3D by 
measuring the distance between the median delineated OAR 
and each individual delineated OAR (2). The variation in 
distance of each OAR was expressed as a standard deviation 
(SD). Furthermore, to assess the overlap between observers 
the concordance index (CI) was calculated. The CI has values 
ranging from 0 for no overlap to 1 for perfect agreement 
between all observers (3). 
 
Results: Seven observers delineated most of the contours in 
the first and second session. Five observers delineated 14 
OARs in both delineation sessions. For fair comparison 
between first and second delineation session, observer 
variability was only calculated among the five observers who 
delineated all 14 OARs in both sessions. The average 3D 
variation in distance for the first and second session was 3.0 
mm and 2.1 mm (1 SD), respectively (Table 1).  
 
 
Out of 14 OARs, 11 OARs showed reduced 3D variation 
(reduction range 0.3-3.7 mm) using the consensus guidelines. 
The largest reduction of 3.7 mm was seen for the oral cavity, 
from 5.8 mm to 2.1 mm (Figure 1). 
 
For 3 OARs (i.e. both submandibular glands and the chiasm) 
the 3D variation was larger using the guidelines (range 0.2-
1.0 mm). For the first and second session, the average CI was 
0.29 and 0.40, respectively (Table 1). For 11 OARs an 
improvement of the CI was seen (improvement range 0.03 – 
0.31). The largest improvement was again seen for the oral 
cavity from 0.36 to 0.67. For 3 OARs the CI became worse. 
For the submandibular glands the differences were however 
small; 0.05. 
 
Conclusion: The use of the consensus guidelines for head and 
neck OARs reduced observer variation for most OARs 
investigated. This stresses the importance to use uniform 
internationally accepted guidelines in daily clinical practice, 
